Obesity definition for personalised treatment of type 2 diabetes

Affiliations

¹ Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LJ, UK; Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: rajna.golubic@dtu.ox.ac.uk.
² Warwick Medical School, University of Warwick, Warwick, UK.
³ Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Warwick Medical School, University of Warwick, Warwick, UK.

Comment

Rajna Golubic et al. Lancet. 2022.

. 2022 Jun 11;399(10342):2189.

doi: 10.1016/S0140-6736(22)00886-8.

¹ Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LJ, UK; Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: rajna.golubic@dtu.ox.ac.uk.
² Warwick Medical School, University of Warwick, Warwick, UK.
³ Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Warwick Medical School, University of Warwick, Warwick, UK.

No abstract available

Comment in

Obesity definition for personalised treatment of type 2 diabetes Authors' reply.
Lingvay I, Sumithran P, Cohen RV, Roux CWL. Lingvay I, et al. Lancet. 2022 Jun 11;399(10342):2189-2190. doi: 10.1016/S0140-6736(22)00890-X. Lancet. 2022. PMID: 35691319 No abstract available.

Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation.
Lingvay I, Sumithran P, Cohen RV, le Roux CW. Lingvay I, et al. Lancet. 2022 Jan 22;399(10322):394-405. doi: 10.1016/S0140-6736(21)01919-X. Epub 2021 Sep 30. Lancet. 2022. PMID: 34600604 Review.